It is documented that loricrin and involucrin, which are protein component of skin barrier, are significantly decreased in both acute and non-lesioned skin of AD subjects, further proving the flaw in the skin barrier of AD patients (132). This evidence concerns the gene LORICRIN and Alzheimer disease.